EDGAR Filing Documents for 0001731122-23-001762

Form 8-K - Current report:

SEC Accession No. 0001731122-23-001762

Filing Date

2023-09-29

Accepted

2023-09-29 17:24:09

Documents

Period of Report

2023-09-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	e5071_8-k.htm iXBRL	8-K	46234
2	EXHIBIT 2.1	e5071_ex2-1.htm	EX-2.1	719932
3	EXHIBIT 99.1	e5071_ex99-1.htm	EX-99.1	19764
	Complete submission text file	0001731122-23-001762.txt		1110446

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	renb-20230928.xsd	EX-101.SCH	3024
5	XBRL LABEL FILE	renb-20230928_lab.xml	EX-101.LAB	34240
6	XBRL PRESENTATION FILE	renb-20230928_pre.xml	EX-101.PRE	22365
8	EXTRACTED XBRL INSTANCE DOCUMENT	e5071_8-k_htm.xml	XML	3330

Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067

Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840

RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)